Ann Arbor, MI, United States of America

Elke Lipka

This inventor holds 1 USPTO granted patent. Top assignees: Tsrl, Inc., University of Michigan. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Elke Lipka. Retrieved from https://idiyas.com/inventor/elke-lipka

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Elke Lipka

Introduction

Elke Lipka is a prominent inventor based in Ann Arbor, MI (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of prodrugs that enhance the bioavailability of therapeutic agents. Her work has the potential to improve treatment outcomes for various medical conditions.

Latest Patents

One of Elke Lipka's notable patents is focused on "Metabolically stable prodrugs." This patent provides prodrugs of various therapeutic agents that offer enhanced bioavailability. The methods described in her patent involve the administration of these prodrugs to treat specific conditions in subjects. The prodrug includes a therapeutic agent covalently attached to a cap, which has a specific structural formula that includes various alkyl and cycloalkyl groups.

Career Highlights

Throughout her career, Elke Lipka has worked with reputable organizations, including Tsrl, Inc. and the University of Michigan. Her experience in these institutions has allowed her to collaborate with other experts in the field and contribute to innovative research.

Collaborations

Some of her notable coworkers include Eric Simon and Andy D White. Their collaborative efforts have further advanced the research and development of new therapeutic solutions.

Conclusion

Elke Lipka's innovative work in the field of prodrugs exemplifies her commitment to enhancing medical treatments. Her contributions continue to influence the pharmaceutical industry and improve patient care.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…